Post by The Global Fund
208,587 followers
A new breakthrough could end AIDS. Lenacapavir (LEN) is a twice-yearly injection that is nearly 100% effective at preventing HIV – offering a long-acting alternative to daily prevention methods. It represents a major shift in HIV prevention, making protection simpler and more accessible. But innovation alone doesn’t save lives. It must reach those who need it most. LEN marks the first time a major HIV prevention tool has been made available in both high- and low-income countries in the same year. With The Global Fund partnership support, 24 countries will receive LEN by the end of this year. If we move fast, an AIDS-free generation is within reach.
Video Content